SCHEMBL2201947

SCHEMBL2201947

O=C(NCc1ccc(Br)cc1)c1ccc2cccnc2c1O

nearest known ligand 0.79

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 16/20 0.79
ALDH1A1 P00352 1/20 0.55
LMNA P02545 1/20 0.49
POLB P06746 1/20 0.49
MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2200760 0.88 EGLN1 (1.00) EGLN1ALDH1A1MAPT
SCHEMBL7688599 0.88 EGLN1 (0.80) EGLN1ALDH1A1
SCHEMBL12697382 0.88 EGLN1 (0.79) EGLN1ALDH1A1
SCHEMBL2206131 0.88 EGLN1 (1.00) EGLN1ALDH1A1LMNAPOLB
SCHEMBL2204239 0.87 EGLN1 (0.83) EGLN1ALDH1A1MAPT
SCHEMBL2144304 0.87 EGLN1 (0.60) EGLN1LMNAPOLBMAPT
SCHEMBL2203014 0.84 EGLN1 (0.74) EGLN1ALDH1A1MAPT
SCHEMBL2201315 0.84 EGLN1 (1.00) EGLN1ALDH1A1LMNAMAPT
SCHEMBL2205303 0.84 EGLN1 (0.74) EGLN1ALDH1A1
SCHEMBL7689313 0.83 EGLN1 (0.72) EGLN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105168213-A Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA 2015-12-23 CN claimed
US-8969380-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA (LU) 2015-03-03 US claimed
US-8729076-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives POLICHEM SA (LU) 2014-05-20 US claimed
CN-102712596-B Secondary 8-hydroxyquinoline-7-carboxamide derivatives POLICHEM SA 2014-04-09 CN claimed
EP-2519504-B1 NEW SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES. POLICHEM SA (LU) 2014-03-19 EP claimed
EP-2519503-B1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM SA (LU) 2013-10-23 EP claimed
US-20120329797-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM SA (LU) 2012-12-27 US claimed
US-20120316167-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES POLICHEM SA (LU) 2012-12-13 US claimed
EP-2519504-A1 NEW SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES. Polichem SA (LU) 2012-11-07 EP claimed
EP-2519503-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM S.A. (LU) 2012-11-07 EP claimed
CN-102712597-A Secondary 8-hydroxyquinoline-7-carboxamide derivatives as antifungal agents POLICHEM SA 2012-10-03 CN claimed
CN-102712596-A novel secondary 8-hydroxyquinoline-7-carboxamide derivatives POLICHEM SA 2012-10-03 CN claimed
EP-2345642-A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM S.A. (LU) 2011-07-20 EP claimed
EP-2345641-A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives POLICHEM S.A. (LU) 2011-07-20 EP claimed
WO-2011080266-A1 NEW SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES. POLICHEM S.A. (LU) 2011-07-07 WO claimed
WO-2011080265-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM S.A. (LU) 2011-07-07 WO claimed
CN-105168213-A Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA 2015-12-23 CN disclosed
US-8969380-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA (LU) 2015-03-03 US disclosed
WO-2011080266-A1 NEW SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES. POLICHEM S.A. (LU) 2011-07-07 WO disclosed
WO-2011080265-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM S.A. (LU) 2011-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120329797-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS ERG28, TUBA8, CYP51A1 EGLN1 1246/4885ALDH1A1 1232/4885LMNA 3608/4885
US-20120316167-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES TUBA8, CYP51A1, ERG28 EGLN1 946/4885ALDH1A1 1383/4885LMNA 3555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.